PatientsLikeMe and Shire Pharmaceuticals Collaborate to Study Rare Genetic Diseases

Primary tabs

PatientsLikeMe and Shire Pharmaceuticals Collaborate to Study Rare Genetic Diseases

tweet me:
.@Shireplc and @patientslikeme announce collaboration, furthering understanding of #rarediseases http://bit.ly/2oINtTq #healthcare
Monday, April 24, 2017 - 11:30am

CONTENT: Press Release

CAMBRIDGE, Mass., April 18, 2017 /3BL Media/ -- PatientsLikeMe and Shire plc have announced a new collaboration that will support the development of a patient-centered, real world health learning system that expands understanding of patient health and disease. Philip Vickers, PhD, Head of Research and Development for Shire, said working with PatientsLikeMe will help the company overcome some of the traditional challenges inherent in understanding rare diseases. "Establishing regular connections with patients and their caregivers has been challenging for researchers studying rare diseases."

http://www.businesswire.com/news/home/20170410005220/en/PatientsLikeMe-Shire-Pharmaceuticals-Collaborate-Study-Rare-Genetic/

Keywords: Health & Healthcare | Chronic Illness | Disease Awareness | Healthcare Innovation | Partnerships | PatientsLikeMe | Pharma News, Research & Solutions | Shire | rare diseases

CONTENT: Press Release